BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wahl RU, Leijs M, Araujo A, Rübben A. Correlative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma-An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy of Cancer. Int J Mol Sci 2020;21:E2020. [PMID: 32188047 DOI: 10.3390/ijms21062020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Persa OD, Schatton K, Rübben A, Berking C, Erdmann M, Schlaak M, Mauch C, Steeb T. Risk Factors for Relapse after Intentional Discontinuation of Immune Checkpoint Inhibitors in Melanoma Patients. J Immunother 2021;44:239-41. [PMID: 34028389 DOI: 10.1097/CJI.0000000000000375] [Reference Citation Analysis]
2 Argentiero A, Solimando AG, Ungaro V, Laforgia M, Strippoli S, Pinto D, Negri A, Ferraiuolo S, Zito A, Guida M. Case Report: Lymphocytosis Associated With Fatal Hepatitis in a Thymoma Patient Treated With Anti-PD1: New Insight Into the Immune-Related Storm. Front Oncol 2020;10:583781. [PMID: 33381454 DOI: 10.3389/fonc.2020.583781] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jain PP, Lai N, Xiong M, Chen J, Babicheva A, Zhao T, Parmisano S, Zhao M, Paquin C, Matti M, Powers R, Balistrieri A, Kim NH, Valdez-Jasso D, Thistlethwaite PA, Shyy JY, Wang J, Garcia JGN, Makino A, Yuan JX. TRPC6, a Therapeutic Target for Pulmonary Hypertension. Am J Physiol Lung Cell Mol Physiol 2021. [PMID: 34704831 DOI: 10.1152/ajplung.00159.2021] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]